ArticleJournal of orthopaedics2025
Body mass index does not increase risk of complications after reverse total shoulder arthroplasty.
Article in Journal of orthopaedics, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Introduction: As obesity rates continue to rise in the United States, understanding the long-term impact of body mass index (BMI) on outcomes following reverse total shoulder arthroplasty (rTSA) is increasingly important. While prior studies have yielded conflicting results, limited data exist on functional outcomes beyond five years postoperatively. Methods: We conducted a retrospective study of 50 shoulders that underwent primary rTSA by a single surgeon, with a mean follow-up of 6.7 years. Patients were stratified into two groups based on BMI: <30 (n = 37) and ≥30 (n = 13). Demographics, range of motion (ROM), patient-reported outcome measures (PROMs), and implant survival were compared between groups. Statistical analyses included t-tests, χ Results: Both BMI cohorts experienced significant improvements in ROM and PROMs postoperatively. Forward elevation improved from 81.3° to 133.5° (p < .01), and VAS pain scores decreased from 6.1 to 1.7 (p < .01). There were no statistically significant differences between BMI groups in final ROM, ASES, SST, or VAS scores. Implant survival was similar between groups. No significant correlations were found between BMI and long-term functional outcomes. Conclusion: BMI does not significantly affect long-term clinical or functional outcomes following rTSA. Despite higher BMI posing potential perioperative challenges, obese patients can achieve comparable improvements in pain, ROM, and quality of life. These findings support the efficacy of rTSA across BMI categories when appropriate perioperative care is provided.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.